Adult and pediatric patients with neurofibromatosis type 1 who have symptomatic plexiform neurofibromas that are not amenable ...
AB (market cap: $16.28M), a company in the development stage, provided insights into its Q4 2024 performance and future plans during its recent earnings call. The company is advancing its Neola ...
Hosted on MSN1d
Biocurious: Hut Hut Hut! The growing list of ASX biotechs waiting for the FDA to call the start of playA large number of Australian biotechs are waiting for US FDA product approval – or are on the cusp of ... Read More The post ...
South Korea showcases top 10 innovative medical devices at annual report meeting South Korea reveals its top ten groundbreaking healthcare technologies at a major annual event ...
Securing FDA clearance or approval is a major accomplishment for medical device and pharmaceutical companies, but it’s not ...
The 10% tariffs on Chinese goods began Tuesday. China reacted with a 15% tariff on coal and liquefied natural gas and a 10% tariff on crude oil, agricultural machinery, large-displacement automobiles ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback